Jiangsu Hengrui Medicine
600276.SS
#467
Rank
HK$342.00 B
Marketcap
HK$53.61
Share price
-1.00%
Change (1 day)
3.24%
Change (1 year)
Jiangsu Hengrui Medicine Company Limited is a Chinese pharmaceutical company engaged in the R&D, manufacturing and sales of healthcare products, including antineoplastic drugs, angiomyocardiac drugs, drugs for surgery, contrast agents and antibiotics

Jiangsu Hengrui Medicine (600276.SS) - Total debt

Total debt on the balance sheet as of September 2024 : HK$97.12 Million

According to Jiangsu Hengrui Medicine 's latest financial reports the company's total debt is HK$97.12 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

Jiangsu Hengrui Medicine - Total debt on balance sheet (from 2000 to 2024)

Total debt by year

Year Total debt Change
2022-12-31HK$1.54 B730.44%
2021-12-31HK$0.18 B
2015-12-31HK$11.99 M-4.25%
2014-12-31HK$12.52 M-51.12%
2013-12-31HK$25.62 M106.13%
2012-12-31HK$12.43 M-49.7%
2011-12-31HK$24.71 M5%
2010-12-31HK$23.53 M107.36%
2009-12-31HK$11.35 M
2007-12-31HK$64.13 M34.11%
2006-12-31HK$47.82 M3.68%
2005-12-31HK$46.12 M-50.44%
2004-12-31HK$93.06 M-73.88%
2003-12-31HK$0.35 B47.46%
2002-12-31HK$0.24 B1.83%
2001-12-31HK$0.23 B37.86%
2000-12-31HK$0.17 B-11.58%
1999-12-31HK$0.19 B44.6%
1998-12-31HK$0.13 B10.2%
1997-12-31HK$0.12 B